Ikena Oncology, Inc.IKNANASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+124.3%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+124.3%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
11.3x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 2025245.28%
Q3 2025-824.96%
Q2 202568.17%
Q1 20255.26%
Q4 20249.52%
Q3 202425.00%
Q2 202415.15%
Q1 202419.51%
Q4 2023-2.50%
Q3 20239.09%
Q2 2023-12.82%
Q1 2023-8.33%
Q4 202221.74%
Q3 202216.36%
Q2 2022-19.57%
Q1 2022-689.74%
Q4 2021119.50%
Q3 2021-14.29%
Q2 202186.11%
Q1 2021-35.48%
Q4 2020-322.73%
Q3 2020-22.22%
Q2 202028.00%
Q1 202074.09%
Q4 20190.00%